Results 1 to 10 of about 3,926 (202)

Prevalence of malaria in an area receiving seasonal malaria chemoprevention in Niger [PDF]

open access: goldMalaria Journal, 2021
Background Malaria transmission is highly seasonal in Niger. Despite the introduction of seasonal malaria chemoprevention (SMC) in the Magaria District, malaria incidence remains high, and the epidemiology of malaria in the community is not well ...
Matthew E. Coldiron   +11 more
doaj   +4 more sources

Status and prospects of seasonal malaria chemoprevention among children in Sahelian countries: A systematic review and meta-analysis. [PDF]

open access: goldPLOS Global Public Health
In areas with seasonal malaria transmission, seasonal malaria chemoprevention (SMC) involves giving children a three-day course of sulfadoxine-pyrimethamine and amodiaquine once a month during the transmission season.
Medard Djedanem   +4 more
doaj   +3 more sources

Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children [PDF]

open access: goldNature Communications, 2019
Seasonal malaria chemoprevention provides substantial benefit for young children, but resistance to used drugs will likely develop. Here, Chotsiri et al.
Palang Chotsiri   +12 more
doaj   +6 more sources

Combining seasonal malaria chemoprevention with novel therapeutics for malaria prevention: a mathematical modelling study. [PDF]

open access: goldPLoS Comput Biol
Abstract Vaccines, monoclonal antibodies, and long-acting injectables are being developed to prevent Plasmodium falciparum malaria. These therapeutics may target multiple stages of the parasite life cycle; evidence is needed to articulate their benefits with chemoprevention and prioritise candidates for clinical development.
Braunack-Mayer L   +5 more
europepmc   +4 more sources

Seasonal malaria chemoprevention in northern Mozambique: a cost-effectiveness analysis [PDF]

open access: yesMalaria Journal
Background Malaria is endemic in Mozambique and one of the leading causes of death in children under 5 years old. In 2020 the country adopted the WHO-recommended seasonal malaria chemoprevention (SMC) strategy and delivered the intervention in all 23 ...
Neide Canana   +9 more
doaj   +4 more sources

Effect of seasonal malaria chemoprevention on incidence of malaria among children under five years in Kotido and Moroto Districts, Uganda, 2021: time series analysis [PDF]

open access: goldMalaria Journal
Background Seasonal malaria chemoprevention (SMC) refers to monthly administration of full treatment courses of anti-malarial medicine to children
Andrew Kwiringira   +8 more
doaj   +4 more sources

Pharmacokinetic considerations in seasonal malaria chemoprevention

open access: hybridTrends in Parasitology, 2022
Los niños africanos menores de 5 años soportan la principal carga de la mortalidad mundial por malaria. La quimioprevención estacional de la malaria (SMC) con sulfadoxina-pirimetamina (SP) más amodiaquina (AQ) administrada mensualmente durante la temporada de lluvias es una intervención altamente efectiva contra la malaria para niños de entre 3 meses y
Palang Chotsiri   +2 more
openalex   +3 more sources

Seasonal vaccination against malaria: a potential use for an imperfect malaria vaccine [PDF]

open access: yesMalaria Journal, 2017
In many parts of the African Sahel and sub-Sahel, where malaria remains a major cause of mortality and morbidity, transmission of the infection is highly seasonal.
Brian Greenwood   +10 more
doaj   +3 more sources

Seasonal malaria chemoprevention: successes and missed opportunities [PDF]

open access: yesMalaria Journal, 2017
Seasonal malaria chemoprevention (SMC) was recommended in 2012 for young children in the Sahel during the peak malaria transmission season. Children are given a single dose of sulfadoxine/pyrimethamine combined with a 3-day course of amodiaquine, once a ...
Matthew E. Coldiron   +2 more
doaj   +3 more sources

Household-level effects of seasonal malaria chemoprevention in the Gambia. [PDF]

open access: yesCommun Med (Lond), 2023
Abstract Background In 2022 the WHO recommended the discretionary expansion of the eligible age range for seasonal malaria chemoprevention (SMC) to children older than 4 years. Older children are at lower risk of clinical disease and severe malaria so there has been uncertainty about the cost ...
Soremekun S   +11 more
europepmc   +7 more sources

Home - About - Disclaimer - Privacy